top of page
Cancer Blog
- Dr. Robert Nagourney -
Search


Re-Examining Cancer Surgery in the Modern Era: The Way Forward.
Over recent years, there has been a re-awakening of non-curative surgeries. This was pioneered by gynecologic oncologists who conducted upfront chemotherapy, known as neoadjuvant, and then after 3 cycles removed the remaining tumor.

Dr. Robert A. Nagourney, MD
Nov 52 min read


Small Comfort for Inoperable Pancreatic Cancer Patients
Patients never have a second chance to receive first-line therapy, yet first-line therapy offers the best chance of durable remission.

Dr. Robert A. Nagourney, MD
Jun 91 min read


What Medical Oncologists Aren’t Telling You About Chemotherapy
These results confirm that the majority of cancer patients in the US today do not respond to the NCCN guideline therapies that their physici

Dr. Robert A. Nagourney, MD
Apr 83 min read


5 Hidden Truths About Cancer Treatment That Functional Profiling Solves
Your life is too important to rely on statistical averages. Get the personalized approach you deserve.

Dr. Robert A. Nagourney, MD
Mar 123 min read


For Advanced Biliary Tract Cancer Patients, the Path Forward
Biliary tract cancer afflicts 8,000 patients in the US each year. It is separated into intrahepatic and and extrahepatic.

Dr. Robert A. Nagourney, MD
Feb 253 min read


For Patients with the Most Advanced Lung Cancers: “Nunquam Cede” (Latin-Never Yield)
I’ve long held that there are no bad cancers, just cancers that we can or cannot treat.

Dr. Robert A. Nagourney, MD
Dec 11, 20243 min read


Why Do Chemotherapy Drugs Work For Some Cancer Patients and Not For Others?
Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.

Dr. Robert A. Nagourney, MD
Nov 19, 20243 min read


Metastatic Breast Cancer Claims Another Life
I received a video from an episode of Americas Got Talent, the popular TV program that features up-and-coming performers.

Dr. Robert A. Nagourney, MD
Sep 26, 20242 min read


Metastatic or Recurrent Cancer Patients Can’t Afford to Guess
Cancer patients deserve better. Every patient is unique. Their treatment should be as well.

Dr. Robert A. Nagourney, MD
Jul 18, 20243 min read


A Ray of Hope in the Fight Against Stage 4 Colon Cancer
Daniel Werner, a dedicated nurse and a loving fiancé and father, faced the grim reality of a stage 4 colon cancer diagnosis in December 2021

Dr. Robert A. Nagourney, MD
Apr 2, 20243 min read


What’s a Pancreatic Cancer Doctor to do? More Importantly: What are Their Patients to do?
Screening for Pancreatic cancer, even in the highest-risk individuals found not cost effective.

Dr. Robert A. Nagourney, MD
Mar 12, 20242 min read


Breakthrough in Pancreatic Cancer: New Blood Test for Early Detection, Could Offer Improved Therapy
Blood test results offer a “cancer signature” that distinguishes patients with pancreatic cancer from normal individuals.

Dr. Robert A. Nagourney, MD
Mar 4, 20242 min read


Functional Profiling for Cancer is Scientifically Validated by Peer-Review
One of the critical advantages of Functional Profiling over traditional genomic testing is its focus on the actual response of cancer cells.

Dr. Robert A. Nagourney, MD
Feb 9, 20242 min read


What Have Medical Oncologists Lost? Empathy!
Cancer patients approach their diagnosis with a sense of terror. One day they are fine and feeling well and the next, a terminal diagnosis.

Dr. Robert A. Nagourney, MD
Jan 31, 20243 min read


For Advanced Cancer Patients: Whose Life is It Anyway?
Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.

Dr. Robert A. Nagourney, MD
Jan 23, 20243 min read


Personalized Medicine Is More Than a Marketing Buzzword at Nagourney Cancer Institute
Cancer therapy can be really expensive. But here's the kicker, Functional Profiling costs way less than receiving the incorrect treatment.

Dr. Robert A. Nagourney, MD
Jan 15, 20242 min read


The Cancer Clinical Trial Process is in Need of Revision
Patients with advanced malignancies often seek the expertise of physicians at major institutions.

Dr. Robert A. Nagourney, MD
Dec 7, 20232 min read


Hitting Cancer True and Straight: the Role of Tissue Analysis
Although she showed some response, her disease persisted and she was being considered for surgery to remove the residual tumor...

Dr. Robert A. Nagourney, MD
Oct 30, 20233 min read


Your Cancer Cure May Already Exist
Personalized treatment means more cured patients. More people survive cancer when our Functional Profiling system is used before treatment.

Dr. Robert A. Nagourney, MD
Sep 26, 20232 min read


“New” Immune Therapy Active in Late-Stage Cancer Patients
Here in 2023, we
suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.

Dr. Robert A. Nagourney, MD
Aug 14, 20233 min read
bottom of page
